Published in J Neural Transm Suppl on January 01, 1991
Cognition, glucose metabolism and amyloid burden in Alzheimer's disease. Neurobiol Aging (2010) 1.19
Diagnosis of suspected Alzheimer's disease is improved by automated analysis of regional cerebral blood flow. Eur J Nucl Med Mol Imaging (2004) 0.86
Current status and future role of brain PET/MRI in clinical and research settings. Eur J Nucl Med Mol Imaging (2015) 0.86
Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals. BMC Med (2012) 0.85
Posterior cingulate metabolic changes in frontotemporal lobar degeneration detected by magnetic resonance spectroscopy. Neuroradiology (2004) 0.76
Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis. Alzheimers Dement (Amst) (2017) 0.75
MAP kinase and cAMP filamentation signaling pathways converge on the unusually large promoter of the yeast FLO11 gene. EMBO J (1999) 3.89
Ras signaling is required for serum-induced hyphal differentiation in Candida albicans. J Bacteriol (1999) 3.09
Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet (1996) 2.92
DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry (2004) 2.91
Identification by positron emission tomography of neuronal loss in acute vegetative state. Lancet (2000) 2.85
Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees. J Virol (1990) 2.65
Differential capacity of left and right hemispheric areas for compensation of poststroke aphasia. Ann Neurol (1999) 2.57
Yeast suppressors of UAA and UAG nonsense codons work efficiently in vitro via tRNA. Cell (1976) 2.16
MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology (2004) 2.07
Current intensity and oxytocin release after electroconvulsive therapy. Biol Psychiatry (1993) 2.04
Cerebral representation of one's own past: neural networks involved in autobiographical memory. J Neurosci (1996) 1.97
The effect of Ghana's National Health Insurance Scheme on health care utilisation. Ghana Med J (2012) 1.93
Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. Brain (2001) 1.93
A high molecular weight precursor of luteinizing hormone releasing hormone from rat hypothalamus. Endocrinology (1983) 1.81
Gonadotrophin-releasing hormone deficiency in a mutant mouse with hypogonadism. Nature (1977) 1.71
Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry (2005) 1.69
Late presentation to HIV/AIDS testing, treatment or continued care: clarifying the use of CD4 evaluation in the consensus definition. HIV Med (2013) 1.57
Transposable elements (Ty) in yeast. Cold Spring Harb Symp Quant Biol (1981) 1.55
Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology (2005) 1.54
HIP-70: a protein induced by estrogen in the brain and LH-RH in the pituitary. Science (1990) 1.52
Which targets are relevant for therapy of acute ischemic stroke? Stroke (1999) 1.51
Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease. Acta Neuropathol (1996) 1.49
Ductus venosus shunting in growth-restricted fetuses and the effect of umbilical circulatory compromise. Ultrasound Obstet Gynecol (2006) 1.49
Increased amino acid transport into brain tumors measured by PET of L-(2-18F)fluorotyrosine. J Nucl Med (1991) 1.46
Gonadotropin-releasing hormone surge in pro-oestrous rats. Nature (1976) 1.43
Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol (2001) 1.42
Comparison of plasma levels of luteinizing hormone releasing hormone in men after intravenous or intranasal administration. J Endocrinol (1974) 1.42
[FEES in the stroke unit: recommendations for implementation in the clinical routine]. Nervenarzt (2013) 1.42
The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett (1993) 1.41
Performance of a randomization test for single-subject (15)O-water PET activation studies. J Cereb Blood Flow Metab (1997) 1.40
Rhodopsin-family receptors associate with small G proteins to activate phospholipase D. Nature (1998) 1.40
Early computed-tomography abnormalities in acute stroke. Lancet (1997) 1.40
Left hemispheric neuronal heterotopia: a PET, MRI, EEG, and neuropsychological investigation of a university student. Neurology (1994) 1.39
[Clinical features and current treatment of hypertensive crisis]. Dtsch Med Wochenschr (2003) 1.39
Gene targeting demonstrates additive detrimental effects of interleukin 1 and tumor necrosis factor during pancreatitis. Gastroenterology (1997) 1.38
HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern. Eur J Nucl Med (1994) 1.38
Predictors of good outcome after intravenous tPA for acute ischemic stroke. Neurology (2001) 1.37
Host-cell positive transcription elongation factor b kinase activity is essential and limiting for HIV type 1 replication. Proc Natl Acad Sci U S A (1999) 1.37
Quality of the family physician component of AMA Masterfile. J Am Board Fam Pract (1996) 1.34
Normal and pathological aging--findings of positron-emission-tomography. J Neural Transm (Vienna) (1998) 1.33
Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab (1992) 1.31
Impaired episodic memory retrieval in a case of probable psychogenic amnesia. Psychiatry Res (1997) 1.29
Stroke following internal carotid artery occlusion - a contra-indication for intravenous thrombolysis? Eur J Neurol (1999) 1.28
Brain plasticity in poststroke aphasia: what is the contribution of the right hemisphere? Brain Lang (1998) 1.24
Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas. Dementia (1994) 1.22
Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence. Neurology (2008) 1.21
The effect of starvation on tissue adenosine 3'-5' monophosphate levels. Biochem Biophys Res Commun (1973) 1.20
Mitochondrial assembly in respiration-deficient mutants of Saccharomyces cerevisiae. IV. Effects of nuclear amber suppressors on the accumulation of a mitochondrially made subunit of cytochrome c oxidase. J Biol Chem (1975) 1.20
Changes in brain metabolism associated with remission in unipolar major depression. Acta Psychiatr Scand (2004) 1.18
Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI). Dement Geriatr Cogn Disord (2009) 1.18
Chemical cross-linking of protein to RNA within intact ribosomal subunits from Escherichia coli. Mol Gen Genet (1978) 1.17
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban. Clin Res Cardiol (2013) 1.17
Plasticity of language networks in patients with brain tumors: a positron emission tomography activation study. Ann Neurol (2001) 1.17
Active interleukin-1 receptor required for maximal progression of acute pancreatitis. Ann Surg (1996) 1.17
Fetal cardiac output, distribution to the placenta and impact of placental compromise. Ultrasound Obstet Gynecol (2006) 1.16
The biology of human immunodeficiency virus-1 IIIB infection in the chimpanzee: in vivo and in vitro correlations. J Med Primatol (1989) 1.15
Disturbance and recovery of language function: correlates in PET activation studies. Neuroimage (2003) 1.15
The use of azidoarylimidoesters in RNA-protein cross-linking studies with Escherichia coli ribosomes. J Mol Biol (1980) 1.14
A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy. Br J Cancer (2001) 1.13
Cerebral blood flow and metabolism during cardiopulmonary bypass: evidence of microembolic encephalopathy. Neurology (1971) 1.13
CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease. Eur J Neurol (2008) 1.10
Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dement Geriatr Cogn Disord (2000) 1.10
Vascular dementia: perfusional and metabolic disturbances and effects of therapy. J Neural Transm Suppl (1996) 1.09
An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies. J Nucl Med (1994) 1.08
Biodistribution, pharmacokinetics and metabolism of interleukin-1 receptor antagonist (IL-1RA) using [¹⁸F]-IL1RA and PET imaging in rats. Br J Pharmacol (2011) 1.07
Molecular recognition of tRNA(Pro) by Escherichia coli proline tRNA synthetase in vitro. Nucleic Acids Res (1995) 1.07
Evidence of anaphylaxy after alteplase infusion. Stroke (1999) 1.07
The production of microemboli by various blood oxygenators. Ann Thorac Surg (1970) 1.06
A comparison of unawareness in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2007) 1.06
Severity and mortality of experimental pancreatitis are dependent on interleukin-1 converting enzyme (ICE). J Interferon Cytokine Res (1997) 1.05
Microemboli during cardiopulmonary bypass detected by ultrasound. Surg Gynecol Obstet (1969) 1.05
Repeat positron emission tomographic studies in transient middle cerebral artery occlusion in cats: residual perfusion and efficacy of postischemic reperfusion. J Cereb Blood Flow Metab (1997) 1.04
The amygdala's contribution to memory--a study on two patients with Urbach-Wiethe disease. Neuroreport (1994) 1.04
Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine(2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. Brain Res Mol Brain Res (1999) 1.03
Pulmonary function in patients with diabetes mellitus. Am J Med Sci (2001) 1.03
Anosognosia in very mild Alzheimer's disease but not in mild cognitive impairment. Dement Geriatr Cogn Disord (2005) 1.03
Hyperuricemia as a prognostic factor in pulmonary arterial hypertension. Respir Med (2003) 1.02
Structure of a variable number tandem repeat of the serotonin transporter gene and association with affective disorder. Psychiatr Genet (1996) 1.02
Feedback actions of target hormones on hypothalamus and pituitary with special reference to gonadal steroids. Annu Rev Physiol (1979) 1.02
Sensory neuropathy associated with Dursban (chlorpyrifos) exposure. Neurology (1993) 1.01
Reagents suitable for the crosslinking of nucleic acids to proteins. Anal Biochem (1980) 1.01
Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology (1992) 1.01
One-year follow-Up in acute stroke patients treated with rtPA in clinical routine. Stroke (2000) 1.01
Early [(11)C]Flumazenil/H(2)O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy. Stroke (2000) 1.01
Speech-induced cerebral metabolic activation reflects recovery from aphasia. J Neurol Sci (1997) 1.00
Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose. J Cereb Blood Flow Metab (1984) 1.00